The melanoma selectivity reflected the inhibition of HDAC-dependent epigenetic regulation of proliferative kinetics, without the involvement of σR signaling, as demonstrated by the lack of inhibitory effects using the hydroxamic-null precursor 3c (Figure 3). The gene discussed is HDAC9; the disease is melanoma.